ARCHIVES

Six-Year Follow Up Of Phase III Sprycel Trial Demonstrates 71 Percent Overall Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 7 | July 27, 2012

Download PDF Visit The Full Archive

Related Articles

Oncotype DX Cancer Test Can Predict Recurrence

November 25, 2011

ACCC Enthusiastically Support New Effort Or Clinical Research

April 3, 1981

Pres. Bill Clinton to Serve as Honorary Chair Of NBCC’s Breast Cancer Deadline 2020

November 16, 2012

In Brief: Robert McKenna Named New President Of Society Of Surgical Oncology, Hiram Polk President Elect

May 13, 1983

NIH Authorization Bills Require NCI To Spend 10% On Cancer control

February 12, 1993

FDA Advisors Oppose Group’s Tamoxifen Trial, But Okay The Idea

July 6, 1990